• Redx to Present Poster on the Potential of RXC008 in Crohn’s Disease at the Inflammatory Bowel Disease Nordic Conference

    Read more
  • RXC004 Phase 2 Combination Arms to Open Enrolment

    Read more
  • Redx to Present at Jefferies London

    Read more
  • Redx Presenting at AFDD Meeting

    Read more
  • Redx to Present RXC004 Phase 1 Combination Data

    Read more
  • Redx to Present Poster at ASN Kidney Week

    Read more
  • Redx Announces First Patient Dosed in Phase 2a Trial for RXC007

    Read more
  • Redx Presents Preclinical Data Confirming Anti-Fibrotic Effects of RXC007 in Immune Mediated Models, and Final Phase 1 Safety Data

    Read more
  • Redx to Present Poster on Encouraging Preclinical Fibrosis Data for RXC007 at the 21st International Colloquium on Lung and Airway Fibrosis

    Read more
  • Redx to Present Preclinical Data Poster for RXC007 at the European Respiratory Society International Congress

    Read more